Trials / Terminated
TerminatedNCT00523471
Blood Test to Measure DNA Damage in Blood
Gamma-H2AX as a Molecular Predictor of Prostate Cancer Radiosensitivity
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To check the radiosensitivity level in individual patients based on their DNA damage level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood test |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2007-08-31
- Last updated
- 2016-02-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00523471. Inclusion in this directory is not an endorsement.